Search PubMed⌕ Search

Biomedical subjects

B Mukherji

Publications and source records attributed to B Mukherji.

88 records · Page 5Linked to original sources

Evidence for fetal antigen in human sarcoma.

A common antigen (S(2)), initially thought to be uniquely associated with human sarcomas, has been found to be widely distributed in patients with other tumors as well. Absorption studies with human embryonic tissues suggest that S(2) may be a fetal antigen. The presence of antibody to S(2) in patients with tumors and in their relatives implies a propensity in these individuals for cellular dedifferentiation which may be a prerequisite for malignant transformation.

Antibodies, Neoplasm↗

In vivo 19F NMR imaging of the cardiovascular system.

A technique is described that permits the 19F nuclear magnetic resonance (NMR) imaging of the vascular system in animals that have been infused with certain perfluorocarbon blood substitutes. The essence of the technique is the selection for imaging of a narrow group of spectral lines from the fluorocarbon using a combination of selective excitation and selective spin echo. For perfluorotributylamine (FTBA), this uses 56% of the available fluorine signal. Both slice and whole body projection images were obtained. The method was studied on an experimental NMR imaging system based on a 1.4 T, 31 cm diameter magnet. Phantom tests showed that misregistration artifacts, due to the imaging of unwanted spectral lines, were negligible. The spatial resolution obtained in a scan time of 8.5 min was approximately 1 mm. The technique was tested with living rats in which 50% of the blood volume was replaced with an emulsion of FTBA. Short echo times, less than 15 ms, were essential to avoid losing signal from flow effects in the larger vessels. Structures identified included the heart, liver, spleen, lungs, kidneys, and major veins. A diffuse fluorine signal seen in most tissues is indicative of tissue perfusion. The problems and possibilities of potential clinical applications are discussed.

Animals↗

Suppressor function of lymphocytes activated in in vitro co-culture against autologous tumor cells and expanded in interleukin-2.

The phenotypic and functional nature of the lymphocytes that have been activated against autologous tumor cells and expanded in Interleukin-2 (IL-2) was studied in the context of their suitability for use in adoptive immunotherapy for cancer. While long-term co-cultures between autologous lymphocytes and tumor cells in the presence of exogenous IL-2 occasionally induced CD8+ cytolytic T cells, a substantial majority of such co-cultures generated predominantly CD4+ non-cytolytic or poorly cytolytic effector cells. In addition, these CD4+ non-cytolytic effector populations, and a number of CD4+ T cell clones derived from them, behaved like functional T suppressor (Ts) cells by elaborating a factor(s) that had profound negative effect(s) on activation of fresh T cells (inhibition of IL-2 synthesis, inhibition of IL-2 receptor [IL-2]-alpha expression, and inhibition of proliferation). Accordingly, infusion of these non-cytolytic populations capable of exhibiting such regulatory properties may have a substantial negative effect on host response toward cancer.

Biological Assay↗

Adoptive transfer of activated human autologous macrophages results in regression of transplanted human melanoma cells in SCID mice.

The potential anti-tumor activity of human macrophages, grown in macrophage colony stimulating factor (M-CSF), was examined in mice homozygous for the mutation severe combined immune deficiency (scid) bearing xenografts of autologous human melanoma. Injection of scid mice, bearing subcutaneous melanoma xenografts, with the cultured macrophages or with the macrophage culture supernatant, once or repeatedly, resulted in partial to complete regression of tumors. Since a large number of such macrophages (greater than 1 x 10(9)) could be grown in vitro for repeated injection, the scid-human chimera can serve as an in vivo model to examine the role of human macrophages in tumor immunity and to explore the potential of the in vitro cultured macrophages in the therapy of cancer.

Animals↗